Valuation : MaaT Pharma

Market Cap 57M 66.15M 53.45M 48.79M 91.91M 6.32B 92.2M 634M 247M 3.19B 248M 243M 10.58B P/E 2026 *
-1.58x
P/E 2027 * -2.72x
Enterprise Value 68.31M 79.27M 64.04M 58.46M 110M 7.58B 110M 760M 296M 3.82B 298M 291M 12.68B EV / Sales 2026 *
7.01x
EV / Sales 2027 * 3.17x
Free-Float
36.85%
Yield 2026 *
-
Yield 2027 * -
1 day+0.17%
1 week-5.17%
Current month+8.81%
1 month+8.04%
3 months+14.37%
6 months-57.99%
Current year-37.11%
1 week 2.94
Extreme 2.94
3.28
1 month 2.72
Extreme 2.725
3.4
Current year 2.32
Extreme 2.32
8.62
1 year 2.32
Extreme 2.32
8.62
3 years 2.32
Extreme 2.32
9.96
5 years 2.32
Extreme 2.32
14.4
10 years 2.32
Extreme 2.32
14.4
Manager TitleAgeSince
Chief Executive Officer - 01/01/2014
Director of Finance/CFO 59 01/11/2024
Chief Tech/Sci/R&D Officer - 24/06/2024
Director TitleAgeSince
Director/Board Member - 01/01/2014
Director/Board Member 57 01/01/2014
Chairman - 01/01/2016
Date Insider Type Main position Quantity % Market Cap.
5/28/26 A Buy

Founder

2,000 0.0106%
1/29/26 A
Seventure Partners SA
SellCompany 25,423 0.1356%
1/28/26 A
Seventure Partners SA
SellCompany 57,964 0.3091%
Change 5-day change 1-year change 3-year change Capi.($)
+0.17%-5.17%-34.24%-51.98% 66.15M
-1.59%-3.35%+64.49%+98.69% 69.54B
-1.34%-0.75%+48.56%+90.63% 64.97B
-8.37%-12.43%+0.14%-15.42% 25.64B
-2.35%-5.75%-12.17%+448.29% 25.89B
+0.30%-0.69%+63.18%+11.93% 26.51B
-0.96%+10.36%+278.86%+438.78% 20.22B
-0.51%+0.23%+33.71%-18.02% 19.98B
-1.91%-4.37%+13.33%+531.29% 15.69B
-1.47%+0.68%+43.67%+145.49% 13.49B
Average -1.80%-0.34%+49.95%+167.97% 28.2B
Weighted average by Cap. -1.93%+0.12%+57.13%+152.78%

Financials

2026 *2027 *
Net sales 9.75M 11.32M 9.14M 8.35M 15.72M 1.08B 15.77M 108M 42.32M 546M 42.48M 41.56M 1.81B 28.88M 33.51M 27.08M 24.72M 46.56M 3.2B 46.71M 321M 125M 1.62B 126M 123M 5.36B
Net income -31.69M -36.78M -29.72M -27.13M -51.1M -3.52B -51.26M -353M -138M -1.77B -138M -135M -5.88B -15.31M -17.77M -14.36M -13.1M -24.69M -1.7B -24.77M -170M -66.45M -857M -66.71M -65.26M -2.84B
Net Debt 11.3M 13.12M 10.6M 9.68M 18.23M 1.25B 18.28M 126M 49.06M 633M 49.25M 48.18M 2.1B 34.5M 40.04M 32.35M 29.53M 55.63M 3.83B 55.8M 384M 150M 1.93B 150M 147M 6.4B
Logo MaaT Pharma
MaaT Pharma is a late-stage biotechnology company and a leader in the development of intestinal microbiota-based drugs designed to modulate the immune system of cancer patients and improve their survival. A pioneer in its field, MaaT Pharma is developing the first immunomodulatory drug candidate based on intestinal microbiota in oncology, currently in phase 3 clinical evaluation. Thanks to its proprietary pooling (combining donations of healthy microbiota) and microbial co-culture technologies, MaaT Pharma is developing standardised drugs with high bacterial diversity, aimed at improving the survival of cancer patients.
Employees
56
Date Price Change Volume
28/08/26 €3.025 +0.17% 28,125
27/08/26 €3.020 +1.00% 22,385
26/08/26 €2.990 -1.64% 23,536
25/08/26 €3.040 -0.16% 32,349
24/08/26 €3.045 -4.55% 80,235
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
3.025EUR
Average target price
6.500EUR
Spread / Average Target
+114.88%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MAAT Stock